Patents
Sitemap › C07 - Organic chemistry › C07K - Peptides › C07K 14 - Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
Patents for C07K 14 - Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof (291,526)
04/2012
04/19/2012WO2012049307A2 Novel n-terminally modified insulin derivatives
04/19/2012WO2012049268A1 Als inhibitor herbicide tolerant beta vulgaris mutants
04/19/2012WO2012049245A1 Method for purification of complement factor h
04/19/2012WO2012049229A1 Estrogen receptor alpha polypeptide sequence, diagnostic and therapeutic applications thereof
04/19/2012WO2012049215A1 Antimicrobial protein
04/19/2012WO2012049173A1 Polypeptides with permease activity
04/19/2012WO2012048877A1 A new dimedon derivative and a method for the purification of pna and peptide oligomers
04/19/2012WO2012048865A2 Nitrilases
04/19/2012WO2012048856A1 Proinsulin with helper sequence
04/19/2012WO2012048667A1 Epidermal growth factor receptor variant lacking exon
04/19/2012WO2012048430A1 Affinity-conjugated nucleoprotein-papaya mosaic virus-like particles and uses thereof
04/19/2012WO2012014083A3 Frataxin mutants
04/19/2012WO2012013742A3 Stabilization of fsh
04/19/2012WO2012007848A3 Meganuclease variants cleaving a dna target sequence in the was gene and uses thereof
04/19/2012WO2011160848A8 Rearranged tt virus molecules for use in diagnosis, prevention and treatment of cancer and autoimmunity
04/19/2012WO2011159684A3 Generation of induced pluripotent stem cells from small volumes of peripheral blood
04/19/2012WO2011159655A3 IL23p19 ANTIBODY INHIBITOR FOR TREATING OCULAR AND OTHER CONDITIONS
04/19/2012WO2011153512A3 Use of compounds with thrombopoietic activity to promote bone growth and healing
04/19/2012WO2011153491A3 Agonists of growth hormone releasing hormone as effectors for survival and proliferation of pancreatic islets
04/19/2012WO2011146518A9 Pegylated c-peptide
04/19/2012WO2011140397A3 Stem cell defined media for xeno-free and feeder free conditions and uses thereof
04/19/2012WO2011140284A3 Conditional superagonist ctl ligands for the promotion of tumor-specific ctl responses
04/19/2012WO2011139629A3 Light targeting molecules and uses thereof
04/19/2012WO2011130618A3 Compositions and methods for producing glycosylated human pdx-1 protein and methods of use therefore
04/19/2012WO2011116396A3 Hepatocyte growth factor fragments that function as potent met receptor agonists and antagonists
04/19/2012WO2011116094A3 Live attenuated chimeric porcine circovirus vaccine
04/19/2012US20120096593 Plants Having Enhanced Yield-Related Traits And/Or Enhanced Abiotic Stress Tolerance And A Method For Making The Same
04/19/2012US20120096592 Plants Having Enhanced Yield-Related Traits and a Method for Making the Same
04/19/2012US20120096590 Methods for increasing plant cell proliferation by functionally inhibiting a plant cyclin inhibitor gene
04/19/2012US20120096587 Isolated polynucleotides and polypeptides, and methods of using same for increasing nitrogen use efficiency, yield, growth rate, vigor, biomass, oil content, and/or abiotic stress tolerance
04/19/2012US20120096585 System for expression of genes in plants
04/19/2012US20120096584 Nucleotide sequences and polypeptides encoded thereby useful for modifying plant characteristics
04/19/2012US20120096583 Methods and compositions for enhanced gene expression through intron free energy reduction
04/19/2012US20120095186 Polyion complex comprising hydrophobized polyamino acid and use of the same
04/19/2012US20120095185 Process for chelating copper ions using cb-te2a bifunctional chelate
04/19/2012US20120095083 Use of triplex structure dna in transferring nucleotide sequences
04/19/2012US20120094937 Mammalian cell surface antigens; related reagents
04/19/2012US20120094936 MalPEG-Hb Conjugate-Containing Compositions for Delivering Nitric Oxide (NO) to Cells
04/19/2012US20120094935 Methods for creating or identifying compounds that bind tumor necrosis factor alpha
04/19/2012US20120094924 Nucleic acid delivery compounds
04/19/2012US20120094915 Anti-mental fatigue drug
04/19/2012US20120094914 Prophylactic or therapeutic agent for rheumatoid arthritis or rheumatoid arthritis-related diseases
04/19/2012US20120094912 MalPEG-Hb Conjugate-Containing Compositions for Delivering Carbon Monoxide (CO) to Cells
04/19/2012US20120094908 Truncated activin type ii receptor and methods of use
04/19/2012US20120094906 Modified erythropoietin (epo) polypeptides that exhibit increased protease resistance and pharmaceutical compositions thereof
04/19/2012US20120094904 Fad4, fad5, fad5-2, and fad6, novel fatty acid desaturase family members and uses thereof
04/19/2012US20120094902 Fast-acting insulin formulation
04/19/2012US20120094895 Method for enhancing phagocytosis of phosphatidylserine-exposing cells
04/19/2012US20120094873 Combinatorial libraries of proteins having the scaffold structure of c-type lectin-like domains
04/19/2012US20120094864 Extracellular allosteric inhibitor binding domain from a tyrosine kinase receptor
04/19/2012US20120094860 Compositions, Antibodies, Asthma Diagnosis Methods, and Methods for Preparing Antibodies
04/19/2012US20120094396 Methods and composition for measuring the amount of vitamin d derivatives
04/19/2012US20120094378 Nucleic acids encoding for antifungal bifunctional molecules for treating fungal infection
04/19/2012US20120094377 Modified Fluorescent Proteins and Methods for Using Same
04/19/2012US20120094365 Molecular motor
04/19/2012US20120094316 Drug Detection
04/19/2012US20120094299 Nucleotide repeat expansion-associated polypeptides and uses thereof
04/19/2012US20120094293 PGC-1ß, A NOVEL PGC-1 HOMOLOGUE AND USES THEREFOR
04/19/2012US20120094271 Selecting for cooperatively interacting molecules
04/19/2012US20120094008 Nano- and Micro- Encapsulation of Biomaterials Into Particles and Capsules by Varying Precipitation Conditions
04/19/2012US20120093921 Immunogenic compositions having low sodium chloride concentration
04/19/2012US20120093919 E2f as a target of hormone refractory prostate cancer
04/19/2012US20120093873 Molecular Interactions in Hematopoietic Cells
04/19/2012US20120093872 Method For Polypeptide Transfer Into Cells
04/19/2012US20120093868 Haemophilus influenzae type b
04/19/2012US20120093863 Hcv vaccines and methods for using the same
04/19/2012US20120093862 Nucleic acid vaccines for prevention of flavivirus infection
04/19/2012US20120093858 Tat-Based Tolerogen Compositions and Methods for Making and Using Same
04/19/2012US20120093855 RSV F VLPs AND METHODS OF MANUFACTURE AND USE THEREOF
04/19/2012US20120093853 Simian Adenovirus Vectors and Methods of Use
04/19/2012US20120093852 Non-lipidated variants of neisseria meningitidis orf2086 antigens
04/19/2012US20120093851 Chlamydia antigens
04/19/2012US20120093850 Compositions for immunising against staphylococcus aureus
04/19/2012US20120093849 Agents for Treatment of HCV and Methods of Use
04/19/2012US20120093847 Recombinant rsv vaccines
04/19/2012US20120093846 Protein for the immunocastration for mammals
04/19/2012US20120093845 Neil3 peptides and vaccines including the same
04/19/2012US20120093844 Antimicrobial peptides based on cmap27
04/19/2012US20120093842 Chimeric receptor genes and cells transformed therewith
04/19/2012US20120093822 Dopamine d2 receptor-disc1 interaction, compositions and methods for modulating same
04/19/2012US20120093820 Prostatitis-Associated Antigens and Methods of Use Thereof
04/19/2012US20120093778 Simian adenovirus nucleic acid and amino acid sequences, vectors containing same, and methods of use
04/19/2012US20120093765 Process for purification of recombinant human granulocyte colony stimulating factor
04/19/2012US20120093737 Light-absorbing compositions and methods of use
04/19/2012US20120093734 Protein-based methods and compositions for the diagnosis of colorectal adenocarcinoma
04/19/2012US20120093716 Use of antisecretory factors (af) for optimizing cellular uptake
04/19/2012CA2851102A1 Biomarker and method for detecting a chronic inflammatory-associated disease
04/19/2012CA2817973A1 Antibodies that bind amyloid oligomers
04/19/2012CA2814673A1 Immunoreactive antigens of mycoplasma heamofelis and diagnostic immunoassay
04/19/2012CA2814670A1 Egfr-based peptides
04/19/2012CA2814591A1 Als inhibitor herbicide tolerant beta vulgaris mutants
04/19/2012CA2814507A1 Microvesicle-based assays
04/19/2012CA2814428A1 Antimicrobial protein
04/19/2012CA2814386A1 Antigen delivery platforms
04/19/2012CA2814143A1 Methods and compositions for treating hemophilia b
04/19/2012CA2813531A1 Pentose and glucose fermenting yeast cell
04/19/2012CA2813522A1 Novel antigen
04/19/2012CA2813513A1 Polypeptides with permease activity
04/19/2012CA2812951A1 Engineered polypeptides having enhanced duration of action
04/19/2012CA2812948A1 Nd2 peptides and methods of treating neurological disease
1 ... 267 268 269 270 271 272 273 274 275 276 277 278 279 280 281 282 283 284 285 286 287 ... 2916